Biblio
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment. Nat Commun. 2024;15(1):3258.
A day 14 endpoint for acute GVHD clinical trials. Transplant Cell Ther. 2024.
.
COVID-19 Outcomes in Children, Adolescents and Young Adults with Cancer. Int J Cancer. 2022.
. Evaluation of elafin as a prognostic biomarker in acute graft-versus-host disease. Transplant Cell Ther. 2021.